BSE filing, BSE: 544773. Summary written from the filing by ALFA Finder's alert engine.
Merritronix Ltd: key numbers
- Share price
- ₹405.00
- Market cap
- ₹708.1 Cr
- Revenue (annual)
- ₹155.9 Cr
- Net profit (annual)
- ₹16.10 Cr
- P/E (TTM)
- 44.0×Sector 36.4×
- Promoter holding
- 62.28%+0.00% QoQ
- FII holding
- 0.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Merritronix Ltd
All →Merritronix Credit Rating
Merritronix's CRISIL rating on its Rs 20 Crore bank facilities was reaffirmed at BBB-/Stable. The facilities were also placed on rating watch with developing implications.
Merritronix Other Announcement
Merritronix Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Merritronix Business Update
Merritronix Ltd released its H1 FY27 business update, reporting revenue of ₹106.37 Cr. The company outlines operational capacity, order book status, and recent strategic partnerships.
- SMT boards capacity p.a.
- 7.65 lakh
- Order book
- ₹101.6 Cr
Merritronix Management Change
Mr. Ramalakshmana Rao Pavuluri has resigned as an Independent Director of Merritronix Limited, effective October 6, 2026. This departure includes his committee memberships.
Merritronix Annual General Meeting
Merritronix Ltd concluded its 38th Annual General Meeting on September 30, 2026. All business agenda items were transacted by the members as per the notice.
Merritronix Annual Report
Merritronix Ltd has submitted its Annual Report for the financial year 2025-26. The filing complies with SEBI listing regulations.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.